Abstract
The authors describe the myositis-specific and myositis-associated antibodies (MSA-s) in idiopathic inflammatory myopathies and dermatomyositis, with particular emphasis on aspects of clinical relevancy. The frequency and clinical significance of MSA-s in 50 dermatomyositis patients at our Clinic are presented. The most common MSA, anti-TIF-1 antibodies were found in 14% of our dermatomyositis patients and they were associated with cancers, in accordance with previous reports. For patients with a high tumor risk, a comprehensive tumor research using all imaging devices should be performed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
